Background Endoscopic skull‐base surgery (ESBS) is employed in the management of
diverse skull‐base pathologies. Paralleling the increased utilization of ESBS, the literature in …

Acromegaly is typically caused by a growth hormone–secreting pituitary adenoma, driving
excess secretion of insulin-like growth factor 1. Acromegaly may result in a variety of …

The classification of adenohypophysial neoplasms as “pituitary neuroendocrine
tumors”(PitNETs) was proposed in 2017 to reflect their characteristics as epithelial …

Background Microscopic transsphenoidal surgery (mTSS) is a well-established method to
address adenomas of the pituitary gland. Endoscopic transsphenoidal surgery (eTSS) has …

Acromegaly is associated with high morbidity and elevated mortality when not adequately
treated. Surgery is the first-line treatment for most patients as it is the only one that can lead …

Purpose Biochemical control is the main determinant of survival, clinical manifestations and
comorbidities in acromegaly. Transsphenoidal selective adenomectomy (TSA) is the initial …

Purpose The aim of this systematic review is to evaluate the long-term endocrine outcomes
and postoperative complications following endoscopic vs. microscopic transsphenoidal …

Purpose Currently, endoscopic transsphenoidal surgery (ETS) and microscopic
transsphenoidal surgery (MTS) are commonly applied treatments for patients with pituitary …

In this paper, the currently used and well evaluated techniques for the surgery of pituitary
tumors will be reviewed. Since the first surgical approaches to pituitary tumors more than …

Background: Although microscopic (MTSS) and endoscopic transsphenoidal surgery (ETSS)
are both effective approaches for treating non-functioning pituitary adenomas (NFPA) and …